about
Non-alcoholic fatty liver disease: what the clinician needs to know.The Pathogenesis of Nonalcoholic Fatty Liver Disease: Interplay between Diet, Gut Microbiota, and Genetic BackgroundThe Natural Course of Non-Alcoholic Fatty Liver DiseaseOxidative Stress in the Healthy and Wounded Hepatocyte: A Cellular Organelles PerspectiveMetabonomic window into hepatitis B virus-related hepatic diseasesNicotinamide ameliorates palmitate-induced ER stress in hepatocytes via cAMP/PKA/CREB pathway-dependent Sirt1 upregulationNon-alcoholic fatty liver disease: An expanded reviewAlcoholic cardiomyopathy: pathophysiologic insightsDifferent Effects of Eicosapentaenoic and Docosahexaenoic Acids on Atherogenic High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice.A Class of Diacylglycerol Acyltransferase 1 Inhibitors Identified by a Combination of Phenotypic High-throughput Screening, Genomics, and GeneticsAnti-lipoapoptotic effects of Alisma orientalis extract on non-esterified fatty acid-induced HepG2 cells.Bai-Hu-Jia-Ren-Shen-Tang Decoction Reduces Fatty Liver by Activating AMP-Activated Protein Kinase In Vitro and In Vivo.Fatty Acid Transport Proteins: Targeting FATP2 as a Gatekeeper Involved in the Transport of Exogenous Fatty Acids.Hepatic and serum lipid signatures specific to nonalcoholic steatohepatitis in murine models.Altered DNA methylation associated with an abnormal liver phenotype in a cattle model with a high incidence of perinatal pathologies.Cytochrome P450-2E1 promotes fast food-mediated hepatic fibrosis.Novel PPARα agonist MHY553 alleviates hepatic steatosis by increasing fatty acid oxidation and decreasing inflammation during aging.The Dual Role of Nrf2 in Nonalcoholic Fatty Liver Disease: Regulation of Antioxidant Defenses and Hepatic Lipid Metabolism.Innate Immunity and Inflammation in NAFLD/NASH.Lipidomic Evaluation of Aryl Hydrocarbon Receptor-Mediated Hepatic Steatosis in Male and Female Mice Elicited by 2,3,7,8-Tetrachlorodibenzo-p-dioxin.Fructose and NAFLD: The Multifaceted Aspects of Fructose Metabolism.Loss of miR-141/200c ameliorates hepatic steatosis and inflammation by reprogramming multiple signaling pathways in NASH.What Is Lipotoxicity?Non-Alcoholic Fatty Liver Disease.Liraglutide reduces hepatic glucolipotoxicity‑induced liver cell apoptosis through NRF2 signaling in Zucker diabetic fatty rats.IDH2 Deficiency Aggravates Fructose-Induced NAFLD by Modulating Hepatic Fatty Acid Metabolism and Activating Inflammatory Signaling in Female Mice.
P2860
Q24563068-D73BAAE3-8CE1-4B6A-A36B-47A27DA98DBFQ26744380-F315EEDB-2203-46C4-8F30-8272B1C3F1C4Q26746947-1FC754BF-F858-4235-B9EF-13CADCA37866Q26770805-965DEEA4-7DEC-4B88-91AB-18332CEBF83AQ26771253-BE900A3C-E810-45E2-A6A8-57F13CA9F92EQ33731432-248E91CE-3F12-4C78-9A38-D238BBB07838Q33789868-C7289EC6-9064-4926-8B62-93FC20788C6EQ34255727-E93EA386-7572-4A3B-95F2-4F3102FF204FQ36059065-A73628C6-588A-4B57-8989-4C9D70889163Q36080184-8AA8ADA9-377A-48D4-A942-CD32CC974919Q36085347-53DE9E36-8D96-4001-9F45-0E78BCE5BACCQ36174315-84C0E0C9-9864-4491-BD26-B9D7467FE5EFQ37102291-527EF5F9-EF6F-4CE2-865F-F936606AC4F4Q37166770-5CB97E04-09C4-4BDE-B495-7C56DF5965A8Q37497610-E5CB3610-BFCB-445D-9BF1-6504EB860D9BQ37554361-0EA52FD4-DB84-43EC-8D9C-2A8526ED35F6Q38402537-F55E93C6-73C2-4F43-AF87-D01ECCE1AA82Q38539752-AA587FD1-1D74-4EB2-865E-EBDA4012B5BDQ38721837-A6E0852C-8AB7-4FDE-8EFB-BF23D2F75271Q38941605-C53FC6F7-3BB9-43C7-BA75-908618A86748Q39168770-1C8C862B-BAC3-451B-9B0C-0A8209CCD200Q46270590-F13972B6-26EA-4C14-AC4A-D45B3DE856EEQ46355683-B83BD8D4-9586-4973-B1A0-8BD2F70B3E0FQ50957769-D6FE61C9-37AB-4464-B52C-002FE2AA8CB8Q54946966-4AD51903-907D-4769-ADA0-1F26B7A7DE1EQ55456043-816D7BEC-8A87-41EC-BF72-4D9617B7EB26
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Lipotoxicity in the liver.
@ast
Lipotoxicity in the liver.
@en
type
label
Lipotoxicity in the liver.
@ast
Lipotoxicity in the liver.
@en
prefLabel
Lipotoxicity in the liver.
@ast
Lipotoxicity in the liver.
@en
P2093
P2860
P356
P1476
Lipotoxicity in the liver.
@en
P2093
Eva Kereszturi
Gábor Bánhegyi
Laura Simon-Szabó
Veronika Zámbó
P2860
P304
P356
10.4254/WJH.V5.I10.550
P577
2013-10-01T00:00:00Z